Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy

BACKGROUND: BRCA1 and BRCA2 gene mutations are responsible for 5% of breast cancer (BC) and 10–15% of ovarian cancer (EOC). The presence of a germline mutation and therefore the identification of subjects at high risk of developing cancer should ideally precede the onset of the disease, so that appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Negri, Serena, De Ponti, Elena, Sina, Federica Paola, Sala, Elena, Dell'Oro, Cristina, Roversi, Gaia, Lazzarin, Sara, Delle Marchette, Martina, Inzoli, Alesssandra, Toso, Claudia, Fumagalli, Simona, Campanella, Maria, Kotsopoulos, Joanne, Fruscio, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747548/
https://www.ncbi.nlm.nih.gov/pubmed/36307994
http://dx.doi.org/10.1002/mgg3.2071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747548/
https://www.ncbi.nlm.nih.gov/pubmed/36307994
http://dx.doi.org/10.1002/mgg3.2071

Ejemplares similares